AAAAAA
Results: 26-41/41
Authors:
McCarty, OJT
Mousa, SA
Bray, PF
Konstantopoulos, K
Citation: Ojt. Mccarty et al., Immobilized platelets support human colon carcinoma cell tethering, rolling, and firm adhesion under dynamic flow conditions, BLOOD, 96(5), 2000, pp. 1789-1797
Authors:
Colman, RW
Jameson, BA
Lin, YZ
Johnson, D
Mousa, SA
Citation: Rw. Colman et al., Domain 5 of high molecular weight kininogen (kininostatin) down-regulates endothelial cell proliferation and migration and inhibits angiogenesis, BLOOD, 95(2), 2000, pp. 543-550
Authors:
Kim, S
Bell, K
Mousa, SA
Varner, JA
Citation: S. Kim et al., Regulation of angiogenesis in vivo by ligation of integrin alpha 5 beta 1 with the central cell-binding domain of fibronectin, AM J PATH, 156(4), 2000, pp. 1345-1362
Authors:
Mousa, SA
Citation: Sa. Mousa, Antiplatelet therapies: from aspirin to GPIIb/IIIa-receptor antagonists and beyond, DRUG DISC T, 4(12), 1999, pp. 552-561
Authors:
Mousa, SA
Citation: Sa. Mousa, Anti-integrins as a potential therapeutic target in angiogenesis, EXPERT OP T, 9(9), 1999, pp. 1237-1248
Authors:
Mousa, SA
Kapil, R
Mu, DX
Citation: Sa. Mousa et al., Intravenous and oral antithrombotic efficacy of the novel platelet GPIIb/IIIa antagonist roxifiban (DMP754) and its free acid form, XV459, ART THROM V, 19(10), 1999, pp. 2535-2541
Authors:
Wityak, J
Tobin, AE
Mousa, SA
Wexler, RR
Olson, RE
Citation: J. Wityak et al., Isoxazoline GPIIb/IIIa antagonists bearing a phosphoramidate, BIOORG MED, 9(2), 1999, pp. 123-126
Authors:
Confalone, PN
Jin, FQ
Mousa, SA
Citation: Pn. Confalone et al., Platelet glycoprotein IIb/IIIa receptor antagonists derived from isoxazolidines, BIOORG MED, 9(1), 1999, pp. 55-58
Authors:
Mousa, SA
Lorelli, W
Campochiaro, PA
Citation: Sa. Mousa et al., Role of hypoxia and extracellular matrix-integrin binding in the modulation of angiogenic growth factors secretion by retinal pigmented epithelial cells, J CELL BIOC, 74(1), 1999, pp. 135-143
Authors:
Kerr, JS
Wexler, RS
Mousa, SA
Robinson, CS
Wexler, EJ
Mohamed, S
Voss, ME
Devenny, JJ
Czerniak, PM
Gudzelak, A
Slee, AM
Citation: Js. Kerr et al., Novel small molecule alpha v integrin antagonists: Comparative anti-cancerefficacy with known angiogenesis inhibitors, ANTICANC R, 19(2A), 1999, pp. 959-968
Authors:
Mousa, SA
Lorelli, W
Mohamed, S
Batt, DG
Jadhav, PK
Reilly, TM
Citation: Sa. Mousa et al., alpha(v)beta(3) integrin binding affinity and specificity of SM256 in various species, J CARDIO PH, 33(4), 1999, pp. 641-646
Authors:
Barrett, JS
Yu, J
Kapil, R
Padovani, P
Brown, F
Ebling, WF
Corjay, MH
Reilly, TM
Bozarth, JM
Mousa, SA
Pieniaszek, HJ
Citation: Js. Barrett et al., Disposition and exposure of the fibrinogen receptor antagonist XV459 on alpha(IIB)beta(3), binding sites in the guinea pig, BIOPHARM DR, 20(6), 1999, pp. 309-318
Authors:
Olson, RE
Sielecki, TM
Wityak, J
Pinto, DJ
Batt, DG
Frietze, WE
Liu, J
Tobin, AE
Orwat, MJ
Di Meo, SV
Houghton, GC
Lalka, GK
Mousa, SA
Racanelli, AL
Hausner, EA
Kapil, RP
Rabel, HR
Thoolen, MJ
Reilly, TM
Anderson, PS
Wexler, RR
Citation: Re. Olson et al., Orally active isoxazoline glycoprotein IIb/IIIa antagonists with extended duration of action, J MED CHEM, 42(7), 1999, pp. 1178-1192
Authors:
Mousa, SA
Mousa, MA
Citation: Sa. Mousa et Ma. Mousa, Immunocytochemical and histological studies on the hypophyseal-gonadal system in the freshwater Nile tilapia, Oreochromis niloticus (L.), during sexual maturation and spawning in different habitats, J EXP ZOOL, 284(3), 1999, pp. 343-354
Authors:
Mousa, MA
Mousa, SA
Citation: Ma. Mousa et Sa. Mousa, Immunocytochemical study on the localization and distribution of the somatolactin cells in the pituitary gland and the brain of Oreochromis niloticus(Teleostei, Cichlidae), GEN C ENDOC, 113(2), 1999, pp. 197-211
Authors:
Machelska, H
Cabot, PJ
Mousa, SA
Zhang, Q
Stein, C
Citation: H. Machelska et al., Pain control in inflammation governed by selectins, NAT MED, 4(12), 1998, pp. 1425-1428